ZVRA
Zevra (ZVRA)
NASDAQ
$11.06+$0.10 (+0.95%)
Price as of Jun 03, 2026 8:00 PM EDT
  • $685.1M
    Market Cap
  • 22.66%
    1-Year Change
  • Biotechnology
    Industry

Top Holders

Institutional
Mutual Funds
Holder
Ownership %
Shares Held
Change (Shares, %)
Report Date
BLACKROCK, INC.
7.54%
4.5M
-50,575 (-1.13%)
Mar 31, 2026
BLACKROCK FUNDING, INC. /DE
6.90%
4.1M
+958,661 (+23.49%)
Dec 31, 2024
WOODLINE PARTNERS LP
5.84%
3.5M
+99 (+0.003%)
Mar 31, 2026
VANGUARD GROUP INC
5.59%
3.3M
+221,845 (+6.71%)
Dec 31, 2025
FMR LLC
5.43%
3.2M
+818,384 (+25.48%)
Mar 31, 2026
BLACKROCK INC.
4.56%
2.7M
+299,205 (+11.09%)
Jun 30, 2024
NANTAHALA CAPITAL MANAGEMENT, LLC
4.27%
2.5M
+750,000 (+29.74%)
Mar 31, 2026

Current Ownership Distribution

  • Institutions263.1M (99.41%)
  • Insiders1.4M (0.54%)
  • Mutual Funds133,234 (0.05%)
  • Other0 (0.00%)

Insider Transactions

  • 0.54% (1.4M)
    Current InsiderOwnership (%, shares)
  • 2
    Number of InsiderBuying (last 12 months)
  • $366,600.00
    Amount of InsiderBuying (last 12 months)
  • 5
    Number of InsiderSelling (last 12 months)
  • $9.8M
    Amount of InsiderSelling (last 12 months)
Insider Name & Title
Type
Date
Transaction Value
Shares
Share Price
Shares After Transactions
Sangiovanni Timothy J.
SVP, Finance & Corp Controller
Award
May 28, 2026
$0.00
40,000
$0.00
40,000
Sangiovanni Timothy J.
SVP, Finance & Corp Controller
Award
May 28, 2026
$0.00
20,000
$0.00
20,000
Thompson Rahsaan
Chief Legal & Compliance
Sell
May 11, 2026
$20,272.20
1,794
$11.30
48,125
Bode John B
Exempt
Mar 24, 2026
$0.00
39,200
$0.00
19,600
Bode John B
Exempt
Mar 24, 2026
$0.00
39,200
$0.00
0
Bode John B
Exempt
Mar 24, 2026
$194,824.00
39,200
$4.97
84,200
Bode John B
Exempt
Mar 24, 2026
$191,688.00
39,200
$4.89
123,400
Renz Justin A
CFO
Award
Mar 18, 2026
$0.00
300,000
$0.00
300,000
McFarlane Neil F.
President and CEO
Sell
Feb 09, 2026
$125,185.61
14,625
$8.56
387,225
McFarlane Neil F.
President and CEO
Exempt
Feb 07, 2026
$0.00
37,500
$0.00
75,000
McFarlane Neil F.
President and CEO
Exempt
Feb 07, 2026
$0.00
37,500
$0.00
401,850
Sangiovanni Timothy J.
SVP, Finance & Corp Controller
Sell
Feb 03, 2026
$27,548.10
3,000
$9.18
29,590
McFarlane Neil F.
President and CEO
Sell
Feb 02, 2026
$853,425.30
91,000
$9.38
364,350
Schafer Joshua
CCO
Exempt
Jan 31, 2026
$0.00
35,334
$0.00
35,333
Sangiovanni Timothy J.
SVP, Finance & Corp Controller
Exempt
Jan 31, 2026
$0.00
11,666
$0.00
11,668
Schafer Joshua
CCO
Exempt
Jan 31, 2026
$0.00
35,334
$0.00
72,778
McFarlane Neil F.
President and CEO
Exempt
Jan 31, 2026
$0.00
233,334
$0.00
233,333
Sangiovanni Timothy J.
SVP, Finance & Corp Controller
Exempt
Jan 31, 2026
$0.00
11,666
$0.00
32,590
McFarlane Neil F.
President and CEO
Exempt
Jan 31, 2026
$0.00
233,334
$0.00
455,350
Quartel Adrian W
Chief Medical Officer
Exempt
Jan 30, 2026
$0.00
11,333
$0.00
22,667
Sangiovanni Timothy J.
SVP, Finance & Corp Controller
Exempt
Jan 30, 2026
$0.00
6,333
$0.00
12,667
Thompson Rahsaan
Chief Legal & Compliance
Exempt
Jan 30, 2026
$0.00
11,333
$0.00
22,667
Sangiovanni Timothy J.
SVP, Finance & Corp Controller
Exempt
Jan 30, 2026
$0.00
6,333
$0.00
22,674
Quartel Adrian W
Chief Medical Officer
Exempt
Jan 30, 2026
$0.00
11,333
$0.00
14,256
Sangiovanni Timothy J.
SVP, Finance & Corp Controller
Sell
Jan 30, 2026
$15,442.00
1,750
$8.82
20,924
Schafer Joshua
CCO
Exempt
Jan 30, 2026
$0.00
11,333
$0.00
22,667
Quartel Adrian W
Chief Medical Officer
Sell
Jan 30, 2026
$40,035.91
4,533
$8.83
9,723
Thompson Rahsaan
Chief Legal & Compliance
Exempt
Jan 30, 2026
$0.00
11,333
$0.00
53,999
Schafer Joshua
CCO
Exempt
Jan 30, 2026
$0.00
11,333
$0.00
40,819
Thompson Rahsaan
Chief Legal & Compliance
Sell
Jan 30, 2026
$36,009.67
4,080
$8.83
49,919